New mammal species enters human gene mutation equation in Germany:
This article was originally published in Clinica
Executive Summary
A lull in avian flu developments in Europe - since a spate of outbreaks in France recently put the EU on alert - has been broken by the discovery of the H5N1 virus in a new mammalian species in Germany. Although the infection of a stone marten has been attributed to contact with infected wild birds, the World Health Organization says it could indicate changes in the virus, which might facilitate human infection. "Further investigation is needed to determine whether evidence of H5N1 infection in new mammalian species has any significance for the risk of human infection or the potential of this virus to adapt to mammals, including humans," said the WHO.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.